API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/06/20/2901371/0/en/Basilea-partners-oncology-drug-candidate-lisavanbulin-with-Glioblastoma-Foundation.html
https://www.globenewswire.com/news-release/2022/04/13/2421542/0/en/Basilea-reports-preclinical-data-on-oncology-drug-candidates-BAL0891-derazantinib-and-lisavanbulin-at-AACR-Annual-Meeting.html